HPE composable infrastructure platform future-proofs IT at Netherlands Cancer Institute case study

HPE Synergy composable infrastructure platform and HPE ProLiant DL380 Gen10 cluster enable the Netherlands Cancer Institute to accelerate research to advance discoveries of new cancer treatments and enhance efficiency.

HPE composable infrastructure platform future-proofs IT at Netherlands Cancer Institute case study

HPE composable infrastructure platform future-proofs IT at Netherlands Cancer Institute case study thumbnail
Download pdf